Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Date and time:  Tuesday 28 March 2023, 16:00 hours (4 p.m. UK GMT)

Location: Hybrid event to be held in the Level 1 Main Meeting Room, Richard Doll Building, Old Road Campus, Oxford OX3 7LF and online via Zoom/Microsoft Teams (meeting link will be sent to attendees prior to event).

To Join: This is a free event, which will be taking place both in-person and online via Zoom/Microsoft Teams. To register your interest in attending this talk please click HERE

Abstract: The presentation will be in two parts.  First, the presentation of methods and results for an estimation of health system expenditure by disease by sex by age for all OECD countries.  Second, and using these results, a simulation study of how future health system expenditure will change for each OECD country if the annual percentage change in disease incidence rates (‘prevention scenario’) of case fatality and remission rates (‘treatment scenario’) is accelerated in order to achieve SDG 3.4 (a 33% reduction in the risk of death from NCD between ages 30 to 70, from 2015 to 2030, within each country).

Bio: Tony is an epidemiologist and public health medicine specialist. He is committed to answering questions about which public health interventions will achieve the greatest improvements in health and social outcomes, reduce inequalities in health, and do so cost-effectively. Whilst principally an epidemiologist, he uses and combines methods from multiple disciplines: biostatistics, economics, econometrics, and computer and data science. 

From 1998 to 2010 Tony was based at the University of Otago, NZ. Since 2019 he has been at the University of Melbourne, where he leads the Population Interventions Unit and the Scalable Health Intervention Evaluation (SHINE) program that determines health and cost impacts of preventive interventions. From 2023 to 2024, he is Chair of the Aotearoa New Zealand Royal Commission on COVID-19 Lessons Learned.



Forthcoming External Talks

The Health Economic and Policy Seminar Series

Wednesday, 03 April 2024 to Saturday, 31 May 2025